Literature DB >> 22480238

Application of NMR metabolomics to search for human disease biomarkers.

Teklab Gebregiworgis1, Robert Powers.   

Abstract

Since antiquity, humans have used body fluids like saliva, urine and sweat for the diagnosis of diseases. The amount, color and smell of body fluids are still used in many traditional medical practices to evaluate an illness and make a diagnosis. The development and application of analytical methods for the detailed analysis of body fluids has led to the discovery of numerous disease biomarkers. Recently, mass spectrometry (MS), nuclear magnetic resonance spectroscopy (NMR), and multivariate statistical techniques have been incorporated into a multidisciplinary approach to profile changes in small molecules associated with the onset and progression of human diseases. The goal of these efforts is to identify metabolites that are uniquely correlated with a specific human disease in order to accurately diagnose and treat the malady. In this review we will discuss recent developments in sample preparation, experimental techniques, the identification and quantification of metabolites, and the chemometric tools used to search for biomarkers of human diseases using NMR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480238      PMCID: PMC6625354          DOI: 10.2174/138620712802650522

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  44 in total

1.  A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.

Authors:  Teklab Gebregiworgis; Helle H Nielsen; Chandirasegaran Massilamany; Arunakumar Gangaplara; Jay Reddy; Zsolt Illes; Robert Powers
Journal:  J Proteome Res       Date:  2016-01-27       Impact factor: 4.466

2.  Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population.

Authors:  Christopher D Hart; Alessia Vignoli; Leonardo Tenori; Gemma Leonora Uy; Ta Van To; Clement Adebamowo; Syed Mozammel Hossain; Laura Biganzoli; Emanuela Risi; Richard R Love; Claudio Luchinat; Angelo Di Leo
Journal:  Clin Cancer Res       Date:  2017-01-12       Impact factor: 12.531

3.  Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients.

Authors:  Hanaa B Atya; Sahar A Ali; Mohamed I Hegazy; Fathia Z El Sharkawi
Journal:  Indian J Clin Biochem       Date:  2017-05-22

4.  NMR Metabolomics Protocols for Drug Discovery.

Authors:  Fatema Bhinderwala; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

5.  Evaluation of sample preparation protocols for quantitative NMR-based metabolomics.

Authors:  Olga A Snytnikova; Anastasiya A Khlichkina; Renad Z Sagdeev; Yuri P Tsentalovich
Journal:  Metabolomics       Date:  2019-05-24       Impact factor: 4.290

6.  Metabolomics Analyses from Tissues in Parkinson's Disease.

Authors:  Fatema Bhinderwala; Shulei Lei; Jade Woods; Jordan Rose; Darrell D Marshall; Eli Riekeberg; Aline De Lima Leite; Martha Morton; Eric D Dodds; Rodrigo Franco; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

7.  Multivariate Analysis in Metabolomics.

Authors:  Bradley Worley; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

8.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

9.  Utilities for quantifying separation in PCA/PLS-DA scores plots.

Authors:  Bradley Worley; Steven Halouska; Robert Powers
Journal:  Anal Biochem       Date:  2012-10-15       Impact factor: 3.365

10.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.